With the advent of new European regulations, as well as the introduction of innovative research methods and technologies, the clinical trial landscape is fast evolving. 

EORTC will be hosting two events in September, addressing the topics of new EU regulations and new research methodologies in clinical trials:

Navigating Safely through the Regulatory Triangle: (Clinical Trials – In vitro Diagnostics – Data Protection) is a one-day course, which examines how the various elements of these regulations come together, and their potential impact on clinical research. It is targeted at: regulatory specialists in (bio)pharma; representatives of patient advocacy groups; and any other person with an interest in clinical trial regulations and drug development competitiveness in Europe.

Where: Brussels, Belgium – When: 7 September 2016

Innovation and Biomarkers in Cancer Drug Development (IBCD), a first-of-a-kind joint meeting by EORTC, NCI, EMA, and AACR explores the complexity of new cancer drug and biomarker development requirements. IBCD 2016 will help forge multi-stakeholder approaches to cancer drug development with new cancer biomarkers, with an extensive scientific programme that includes input from regulators, industry, academia, patients and payers.